191 related articles for article (PubMed ID: 35895622)
21. Outcome of Patients With Head and Neck Squamous Cell Carcinoma Can be Predicted by Expression of eIF4E and Osteopontin in Free Surgical Margins.
Abouhashem NS; Elwan A; Elaidy NF
Appl Immunohistochem Mol Morphol; 2022 May-Jun 01; 30(5):e40-e49. PubMed ID: 35285458
[TBL] [Abstract][Full Text] [Related]
22. Liquid biopsy for mutational profiling of locoregional recurrent and/or metastatic head and neck squamous cell carcinoma.
Galot R; van Marcke C; Helaers R; Mendola A; Goebbels RM; Caignet X; Ambroise J; Wittouck K; Vikkula M; Limaye N; Machiels JH
Oral Oncol; 2020 May; 104():104631. PubMed ID: 32169746
[TBL] [Abstract][Full Text] [Related]
23. Ultra-deep targeted sequencing of advanced oral squamous cell carcinoma identifies a mutation-based prognostic gene signature.
Chen SJ; Liu H; Liao CT; Huang PJ; Huang Y; Hsu A; Tang P; Chang YS; Chen HC; Yen TC
Oncotarget; 2015 Jul; 6(20):18066-80. PubMed ID: 25980437
[TBL] [Abstract][Full Text] [Related]
24. Somatic mutations in tumor and plasma of locoregional recurrent and/or metastatic head and neck cancer using a next-generation sequencing panel: A preliminary study.
Rapado-González Ó; Brea-Iglesias J; Rodríguez-Casanova A; Bao-Caamano A; López-Cedrún JL; Triana-Martínez G; Díaz-Peña R; Santos MA; López-López R; Muinelo-Romay L; Martínez-Fernández M; Díaz-Lagares Á; Suárez-Cunqueiro MM
Cancer Med; 2023 Mar; 12(6):6615-6622. PubMed ID: 36420687
[TBL] [Abstract][Full Text] [Related]
25. Individualized circulating tumor DNA monitoring in head and neck squamous cell carcinoma.
Kogo R; Manako T; Iwaya T; Nishizuka S; Hiraki H; Sasaki Y; Idogawa M; Tokino T; Koide A; Komune N; Yasumatsu R; Nakagawa T
Cancer Med; 2022 Nov; 11(21):3960-3968. PubMed ID: 35352507
[TBL] [Abstract][Full Text] [Related]
26. Comparing Genomic Landscapes of Oral and Cutaneous Squamous Cell Carcinoma of the Head and Neck: Quest for Novel Diagnostic Markers.
Gupta R; Strbenac D; Satgunaseelan L; Cheung VK; Narayanappa H; Ashford B; Mitchell J; Thind A; Palme CE; Ch'ng S; Low TH; Wykes J; Willet CE; Chew T; Yang J; Ranson M; Clark JR
Mod Pathol; 2023 Aug; 36(8):100190. PubMed ID: 37080394
[TBL] [Abstract][Full Text] [Related]
27. Treatment failure and margin status in head and neck cancer. A critical view on the potential value of molecular pathology.
Slootweg PJ; Hordijk GJ; Schade Y; van Es RJ; Koole R
Oral Oncol; 2002 Jul; 38(5):500-3. PubMed ID: 12110346
[TBL] [Abstract][Full Text] [Related]
28. Somatic genomic imbalances in 'tumour-free' surgical margins of oral cancer.
Baldan F; Gnan C; Lazarevic M; Nikolic N; Mio C; Tepavcevic Z; Robiony M; Milasin J; Damante G
Int J Oral Maxillofac Surg; 2023 Aug; 52(8):831-838. PubMed ID: 36639343
[TBL] [Abstract][Full Text] [Related]
29. Targeted next-generation sequencing of 50 cancer-related genes in Japanese patients with oral squamous cell carcinoma.
Nakagaki T; Tamura M; Kobashi K; Omori A; Koyama R; Idogawa M; Ogi K; Hiratsuka H; Tokino T; Sasaki Y
Tumour Biol; 2018 Sep; 40(9):1010428318800180. PubMed ID: 30226113
[TBL] [Abstract][Full Text] [Related]
30. Implications of tumour in resection margins following surgical treatment of squamous cell carcinoma of the head and neck.
Cook JA; Jones AS; Phillips DE; Soler Lluch E
Clin Otolaryngol Allied Sci; 1993 Feb; 18(1):37-41. PubMed ID: 8448889
[TBL] [Abstract][Full Text] [Related]
31. Tumor-related markers in histologically normal margins correlate with locally recurrent oral squamous cell carcinoma: a retrospective study.
Wang X; Chen S; Chen X; Zhang C; Liang X
J Oral Pathol Med; 2016 Feb; 45(2):83-8. PubMed ID: 26260282
[TBL] [Abstract][Full Text] [Related]
32. Genetically altered fields as origin of locally recurrent head and neck cancer: a retrospective study.
Tabor MP; Brakenhoff RH; Ruijter-Schippers HJ; Kummer JA; Leemans CR; Braakhuis BJ
Clin Cancer Res; 2004 Jun; 10(11):3607-13. PubMed ID: 15173066
[TBL] [Abstract][Full Text] [Related]
33. Genetic landscape of metastatic and recurrent head and neck squamous cell carcinoma.
Hedberg ML; Goh G; Chiosea SI; Bauman JE; Freilino ML; Zeng Y; Wang L; Diergaarde BB; Gooding WE; Lui VW; Herbst RS; Lifton RP; Grandis JR
J Clin Invest; 2016 Jan; 126(1):169-80. PubMed ID: 26619122
[TBL] [Abstract][Full Text] [Related]
34. The Prognostic and Therapeutic Value of the Mutational Profile of Blood and Tumor Tissue in Head and Neck Squamous Cell Carcinoma.
Wilson HL; D'Agostino RB; Meegalla N; Petro R; Commander S; Topaloglu U; Zhang W; Porosnicu M
Oncologist; 2021 Feb; 26(2):e279-e289. PubMed ID: 33098199
[TBL] [Abstract][Full Text] [Related]
35. Targeted next-generation sequencing of locally advanced squamous cell carcinomas of the head and neck reveals druggable targets for improving adjuvant chemoradiation.
Tinhofer I; Budach V; Saki M; Konschak R; Niehr F; Jöhrens K; Weichert W; Linge A; Lohaus F; Krause M; Neumann K; Endris V; Sak A; Stuschke M; Balermpas P; Rödel C; Avlar M; Grosu AL; Abdollahi A; Debus J; Belka C; Pigorsch S; Combs SE; Mönnich D; Zips D; Baumann M;
Eur J Cancer; 2016 Apr; 57():78-86. PubMed ID: 26896955
[TBL] [Abstract][Full Text] [Related]
36. Time series analysis of TP53 gene mutations in recurrent HPV-negative vulvar squamous cell carcinoma.
Regauer S; Kashofer K; Reich O
Mod Pathol; 2019 Mar; 32(3):415-422. PubMed ID: 30291345
[TBL] [Abstract][Full Text] [Related]
37. [Clear resection margins to avoid escalation of adjuvant therapy in oropharyngeal squamous cell carcinoma].
Mansour N; Backes C; Becker C; Hofauer B; Knopf A
HNO; 2021 Apr; 69(4):256-262. PubMed ID: 32975607
[TBL] [Abstract][Full Text] [Related]
38. Clonal evolution and heterogeneity in metastatic head and neck cancer-An analysis of the Austrian Study Group of Medical Tumour Therapy study group.
Melchardt T; Magnes T; Hufnagl C; Thorner AR; Ducar M; Neureiter D; Tränkenschuh W; Klieser E; Gaggl A; Rösch S; Rasp G; Hartmann TN; Pleyer L; Rinnerthaler G; Weiss L; Greil R; Egle A
Eur J Cancer; 2018 Apr; 93():69-78. PubMed ID: 29477794
[TBL] [Abstract][Full Text] [Related]
39. Clinical significance of molecular alterations in histologically negative surgical margins of head and neck cancer patients.
de Carvalho AC; Kowalski LP; Campos AH; Soares FA; Carvalho AL; Vettore AL
Oral Oncol; 2012 Mar; 48(3):240-8. PubMed ID: 22104250
[TBL] [Abstract][Full Text] [Related]
40. The utility of molecular diagnostics to predict recurrence of head and neck carcinoma.
Pena Murillo C; Huang X; Hills A; McGurk M; Lyons A; Jeannon JP; Odell E; Brown A; Lavery K; Barrett W; Sherriff M; Brakenhoff R; Partridge M
Br J Cancer; 2012 Sep; 107(7):1138-43. PubMed ID: 22918395
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
